TLC Reports Second Quarter 2021 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan- August 12, 2021 - TLC, a. | August 13, 2021
Experic Hosts Webinar on Combination Drug Products - Pharmaceutical Business review pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
An existing account was found for this email address. Please click Sign in and Subscribe to continue.
We don t have an account for this email address. Please click Create Account and Subscribe to create a new account and subscribe to our email alerts.Already have an account?Don t already have an account?
By clicking Create Account and Subscribe you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice.
Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email address with any third parties. You can unsubscribe whenever you want.
Brandon Evans March 31, 2021
Ampio Pharmaceuticals Inc. [AMEX: AMPE] closed the trading session at $1.80 on 05/26/21. The day’s price range saw the stock hit a low of $1.75, while the highest price level was $1.86. The company report on May 21, 2021 that Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress.
The company’s findings will be showcased to over 400 clinicians, respiratory health and critical care professionals, aerosol scientists, engineers, product development and regulatory experts.
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced details on the company’s poster presentation, “Regulatory Decisions during COVID-19: Efficient Nonclinical Inhalation Toxicology for a Clinical Program,” being given at the 23rd International Congress o